These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 8002199)

  • 1. Multidrug therapy and eye disease in leprosy: a cross-sectional study in the People's Republic of China.
    Courtright P; Hu LF; Li HY; Lewallen S
    Int J Epidemiol; 1994 Aug; 23(4):835-42. PubMed ID: 8002199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lagophthalmos in a multibacillary population under multidrug therapy in the People's Republic of China.
    Courtright P; Lewallen S; Li HY; Hu LF; Yang JW
    Lepr Rev; 1995 Sep; 66(3):214-9. PubMed ID: 7500816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A overview of ocular leprosy after 2 decades of multidrug therapy.
    Lewallen S; Courtright P
    Int Ophthalmol Clin; 2007; 47(3):87-101. PubMed ID: 17667278
    [No Abstract]   [Full Text] [Related]  

  • 4. Fixed-duration multidrug therapy in multibacillary leprosy.
    Li HY; Hu LF; Wu PW; Luo JS; Liu XM
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):230-7. PubMed ID: 9251596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug therapy--the pathway for global leprosy elimination.
    al-Qubati Y; al-Kubati AS
    Indian J Lepr; 2000; 72(4):477-90. PubMed ID: 11212482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of ocular complications in patients with multibacillary leprosy after completion of a 2 year course of multidrug therapy.
    Daniel E; Ffytche TJ; Kempen JH; Rao PS; Diener-West M; Courtright P
    Br J Ophthalmol; 2006 Aug; 90(8):949-54. PubMed ID: 16707521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of "cure by dapsone monotherapy' to the reduction of prevalence of leprosy in the State of Orissa, India, 1983-1993.
    Patnaik PK; McDougall AC
    Indian J Lepr; 1996; 68(3):223-6. PubMed ID: 8889607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is leprosy blindness avoidable? The effect of disease type, duration, and treatment on eye damage from leprosy in Uganda.
    Waddell KM; Saunderson PR
    Br J Ophthalmol; 1995 Mar; 79(3):250-6. PubMed ID: 7703204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular manifestation in treated multibacillary Hansen's disease.
    Parikh R; Thomas S; Muliyil J; Parikh S; Thomas R
    Ophthalmology; 2009 Nov; 116(11):2051-7.e1. PubMed ID: 19766316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends of case detection and other indicators of leprosy in China during 1985-2002.
    Shen JP; Gupte MD; Jiang C; Manickam P; Yu MW; Li WZ
    Chin Med Sci J; 2005 Jun; 20(2):77-82. PubMed ID: 16075742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in leprosy over fifty years in Gudiyatham Taluk, Vellore, Tamil Nadu.
    Norman G; Raja Samuel Bhushanam JD; Samuel P
    Indian J Lepr; 2006; 78(2):167-85. PubMed ID: 16927851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of MDT strategies through epidemiometric modeling.
    Lechat MF; Declercq EE; Misson CB; Vellut CM
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):296-301. PubMed ID: 2115904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leprosy control through multidrug therapy (MDT).
    Noordeen SK
    Bull World Health Organ; 1991; 69(3):263-9. PubMed ID: 1893503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term multidrug therapy in multibacillary leprosy--review of 80 cases in two provinces of China (1983-1988).
    Li HY; Yu XL; Zhang MS; Duan CX; Huang WB; Zhang SB; Zhu K; Ma JF
    Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):622-7. PubMed ID: 2778368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global review of multidrug therapy (MDT) in leprosy.
    Noordeen SK; Lopez Bravo L; Daumerie D
    World Health Stat Q; 1991; 44(1):2-15. PubMed ID: 2068821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug therapy in leprosy can prevent relapse--a retrospective study.
    Biswas S; Mondal KK
    Indian J Lepr; 2002; 74(4):313-8. PubMed ID: 12624979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy.
    Jing Z; Zhang R; Zhou D; Chen J
    Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of ocular morbidity among multibacillary leprosy patients during a 2 year course of multidrug therapy.
    Daniel E; Ffytche TJ; Sundar Rao PS; Kempen JH; Diener-West M; Courtright P
    Br J Ophthalmol; 2006 May; 90(5):568-73. PubMed ID: 16622085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of leprosy and response to treatment in Hong Kong.
    Ho CK; Lo KK
    Hong Kong Med J; 2006 Jun; 12(3):174-9. PubMed ID: 16760543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on risk of leprosy relapses in China: relapses after treatment with multidrug therapy.
    Chen XS; Li WZ; Jiang C; Ye GY
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):379-87. PubMed ID: 10700911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.